Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ADXN

Addex Therapeutics (ADXN)

Addex Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADXN
DateTimeSourceHeadlineSymbolCompany
11/29/20231:00AMGlobeNewswire Inc.Addex Reports Q3 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
11/28/20236:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
11/28/20231:00AMGlobeNewswire Inc.Addex Convenes Extraordinary General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
11/23/20231:00AMGlobeNewswire Inc.Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023NASDAQ:ADXNAddex Therapeutics Ltd
11/14/20231:00AMGlobeNewswire Inc.Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of PatientsNASDAQ:ADXNAddex Therapeutics Ltd
11/08/20236:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
11/08/20231:00AMGlobeNewswire Inc.Addex Regains Nasdaq Listing ComplianceNASDAQ:ADXNAddex Therapeutics Ltd
11/02/20232:00AMGlobeNewswire Inc.Addex Announces Participation in the Bio-Europe 2023 ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
10/23/20236:01AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ADXNAddex Therapeutics Ltd
10/20/20236:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
10/20/20231:00AMGlobeNewswire Inc.Addex Completes ADS Ratio ChangeNASDAQ:ADXNAddex Therapeutics Ltd
10/06/20234:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
10/06/20234:00PMGlobeNewswire Inc.Addex Announces Plan to Implement ADS Ratio ChangeNASDAQ:ADXNAddex Therapeutics Ltd
09/20/20236:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
09/20/20231:00AMGlobeNewswire Inc.Addex mGlu2 NAM Cognition Program Receives €4 Million GrantNASDAQ:ADXNAddex Therapeutics Ltd
09/06/20231:00AMGlobeNewswire Inc.Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
09/05/20236:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
09/05/20236:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
09/05/20231:00AMGlobeNewswire Inc.Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024NASDAQ:ADXNAddex Therapeutics Ltd
09/04/20231:00AMGlobeNewswire Inc.Addex’s Dipraglurant Development in Post-Stroke Recovery Supported by Data Published in BrainNASDAQ:ADXNAddex Therapeutics Ltd
08/11/20234:00PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ADXNAddex Therapeutics Ltd
08/11/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADXNAddex Therapeutics Ltd
08/10/20234:00PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ADXNAddex Therapeutics Ltd
08/10/20236:31AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
08/10/20231:00AMGlobeNewswire Inc.Addex Reports 2023 Half Year and Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
08/04/20231:00AMGlobeNewswire Inc.Addex Therapeutics to Release Half-Year 2023 Financial Results and Host Conference Call on August 10, 2023NASDAQ:ADXNAddex Therapeutics Ltd
08/03/20236:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
08/03/20231:00AMGlobeNewswire Inc.Addex GABAB Positive Allosteric Modulator Program to Receive Additional CHF2.7 Million from Indivior in Extended Substance Use Disorder Research CollaborationNASDAQ:ADXNAddex Therapeutics Ltd
07/24/20236:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
07/24/20231:00AMGlobeNewswire Inc.Addex mGlu2PAM Demonstrates Potential in Substance Use DisorderNASDAQ:ADXNAddex Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:ADXN